Skip to content

Clinical trials

Phase 1 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1 Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20062
20073
20084
20094
20105
20114
20128
20134
20146
20157
20167
20174
20186
201911
20206
202115
20228
202312
20243
20259
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Recruiting17
Unknown status14
Terminated10
Active, not recruiting9
Not yet recruiting7
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
GlaxoSmithKline4
Johns Hopkins University4
Suven Life Sciences Limited4
Mclean Hospital3
Merck Sharp & Dohme LLC3
Oregon Health and Science University3
Posit Science Corporation3
AbbVie2
Avid Radiopharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction146
Alzheimer Disease54
Dementia19
Memory Disorders8
Parkinson Disease6
Schizophrenia6
Cognition Disorders5
Neurodegenerative Diseases5
Inflammation4
Neurocognitive Disorders4

Trials

Showing 76 to 100 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.